Skip to content
Screener

Palvella Therapeutics PVLA Q3 2025 earnings

Reported November 11, 2025 · Before market open

EPS-$1.03Miss by $0.18
EPS estimate-$0.85

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$16.7K
EPS estimate-$1.74

Financials

Q3 2025

Income statement

See full
Operating income-$10.2M-101%
Net income-$11.3M-67.5%
EPS (diluted)-$1.03+73.9%

Balance sheet

See full
Cash & equivalents$63.6M+228%
Total equity$38.7M+144%
Total assets$66.9M+226%

Cash flow

See full
Operating cash flow-$7.9M-187%

FAQ

When did Palvella Therapeutics report Q3 2025 earnings?
Palvella Therapeutics (PVLA) reported Q3 2025 earnings on November 11, 2025 before market open.
What were Palvella Therapeutics's Q3 2025 revenue and EPS?
Palvella Therapeutics reported eps of $-1.03 for Q3 2025.
Did Palvella Therapeutics beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.85 by $0.18.
How did Palvella Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 53.0% from $-2.19.
Where can I find Palvella Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-274378) and the 10-Q periodic report (0001193125-25-276119) directly on SEC EDGAR. The filing index links above go to sec.gov.